KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q4 2025 value amounting to $4.8 million.

  • Vertex Pharmaceuticals' Treasury Shares rose 7777.78% to $4.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.8 million, marking a year-over-year increase of 7777.78%. This contributed to the annual value of $4.8 million for FY2025, which is 7777.78% up from last year.
  • As of Q4 2025, Vertex Pharmaceuticals' Treasury Shares stood at $4.8 million, which was up 7777.78% from $4.5 million recorded in Q3 2025.
  • Vertex Pharmaceuticals' Treasury Shares' 5-year high stood at $7.3 million during Q4 2021, with a 5-year trough of $300000.0 in Q1 2024.
  • Moreover, its 5-year median value for Treasury Shares was $1.8 million (2025), whereas its average is $2.4 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 20416.67% in 2021, then tumbled by 6009.59% in 2022.
  • Over the past 5 years, Vertex Pharmaceuticals' Treasury Shares (Quarter) stood at $7.3 million in 2021, then crashed by 60.1% to $2.9 million in 2022, then crashed by 55.37% to $1.3 million in 2023, then surged by 107.69% to $2.7 million in 2024, then soared by 77.78% to $4.8 million in 2025.
  • Its Treasury Shares was $4.8 million in Q4 2025, compared to $4.5 million in Q3 2025 and $1.8 million in Q2 2025.